Effect of Treatment Naivete on MRI Outcomes with Fingolimod or Injectable Disease-Modifying Therapies in Patients with Multiple Sclerosis: PREFERMS

被引：0
|
作者：
Hunter, Samuel F. [1 ]
Thomas, Florian P. [2 ,3 ]
Meng, Xiangyi [4 ]
Schofield, Lesley [4 ]
Tenenbaum, Nadia [4 ]
Cree, Bruce A. C. [5 ]
机构：
[1] Adv Neurosci Inst, Franklin, TN USA
[2] Hackensack Univ Med Ctr, Hackensack, NJ USA
[3] Seton Hall Univ, Hackensack Meridian Sch Med, Nutley, NJ USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] UCSF Weill Inst Neurosci, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P037
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [31] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [32] Update on disease-modifying therapies for multiple sclerosis
    Vargas, Diana L.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (05) : 883 - 891
  • [33] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Jai Perumal
    Omar Khan
    Current Treatment Options in Neurology, 2012, 14 : 256 - 263
  • [34] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [35] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [36] Oral Disease-Modifying Therapies for Multiple Sclerosis
    Kim, Woojun
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
  • [37] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [38] Current disease-modifying therapies in multiple sclerosis
    Kieseier, BC
    Hartung, HP
    SEMINARS IN NEUROLOGY, 2003, 23 (02) : 133 - 145
  • [39] The influence of disease-modifying therapies on neuropsychiatric outcomes in people with multiple sclerosis
    Freedman, David
    Oh, Jiwon
    Feinstein, Anthony
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1125 - 1125
  • [40] Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis
    E. Ann Yeh
    B. Weinstock-Guttman
    Advances in Therapy, 2011, 28 : 270 - 278
12345